208 related articles for article (PubMed ID: 25568433)
21. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
22. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
23. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest GN; Weekes E; Johnson JK
J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
[TBL] [Abstract][Full Text] [Related]
24. Catheter-related fungemia caused by Candida dubliniensis.
Lai CC; Tsai HY; Chang TC; Hsueh PR
J Microbiol Immunol Infect; 2013 Aug; 46(4):306-8. PubMed ID: 23246304
[TBL] [Abstract][Full Text] [Related]
25. Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care.
Kim S; Ko KS; Moon SY; Lee MS; Lee MY; Son JS
J Korean Med Sci; 2011 Feb; 26(2):297-300. PubMed ID: 21286025
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
27. First three reported cases of nosocomial fungemia caused by Candida auris.
Lee WG; Shin JH; Uh Y; Kang MG; Kim SH; Park KH; Jang HC
J Clin Microbiol; 2011 Sep; 49(9):3139-42. PubMed ID: 21715586
[TBL] [Abstract][Full Text] [Related]
28. First isolation of Candida wangnamkhiaoensis from the blood of immunocompromised paediatric patient.
Tap RM; Ho Betty LS; Ramli NY; Suppiah J; Hashim R; Sabaratnam P; Ginsapu SJ; Gowbei A; Razak MF; Sipiczki M; Ahmad N
Mycoses; 2016 Nov; 59(11):734-741. PubMed ID: 27427490
[TBL] [Abstract][Full Text] [Related]
29. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
[TBL] [Abstract][Full Text] [Related]
30. Cyberlindnera fabianii fungaemia outbreak in preterm neonates in Kuwait and literature review.
Al-Sweih N; Ahmad S; Khan S; Joseph L; Asadzadeh M; Khan Z
Mycoses; 2019 Jan; 62(1):51-61. PubMed ID: 30184277
[TBL] [Abstract][Full Text] [Related]
31. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
33. Candida quercitrusa Candidemia in a 6-Year-Old Child.
Westblade LF; Rostad CA; Hilinski JA; Stanley T; Jerris RC; Wilkey K; Pincus DH
J Clin Microbiol; 2015 Aug; 53(8):2785-7. PubMed ID: 26063864
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
[TBL] [Abstract][Full Text] [Related]
35. Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates.
Turan O; Ergenekon E; Hirfanoğlu IM; Onal EE; Baş VN; Türkyilmaz C; Koç E; Atalay Y
Turk J Pediatr; 2011; 53(1):19-26. PubMed ID: 21534335
[TBL] [Abstract][Full Text] [Related]
36. Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit.
Lin HC; Lin HY; Su BH; Ho MW; Ho CM; Lee CY; Lin MH; Hsieh HY; Lin HC; Li TC; Hwang KP; Lu JJ
J Microbiol Immunol Infect; 2013 Dec; 46(6):456-62. PubMed ID: 23050985
[TBL] [Abstract][Full Text] [Related]
37. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
38. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
39. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility and molecular characterization of Candida spp. from candidemic patients.
Herkert PF; Gomes RR; Muro MD; Pinheiro RL; Fornari G; Vicente VA; Queiroz-Telles F
Rev Iberoam Micol; 2015; 32(4):221-8. PubMed ID: 25681153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
